CIK 0001661181
- Accelerated filer
Organogenesis Holdings Inc.
Sign in to watch- Ticker
- ORGO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 781-575-0775
- Business address
- 85 DAN ROAD, CANTON, MA, 02021
- Former names
- Avista Healthcare Public Acquisition Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-04-22 | Tamaroff Joshua Alexander Director | Grant or award | +18,564 | 18,564 | ||
| 2020-04-22 | Leibowitz Arthur S Director | Grant or award | +18,564 | 23,564 | ||
| 2020-04-22 | MACKIE WAYNE D Director | Grant or award | +18,564 | 118,564 | ||
| 2020-04-22 | Freedman Lori VP and General Counsel | Grant or award | +26,918 | 26,918 | ||
| 2020-04-22 | Freedman Lori VP and General Counsel | Grant or award · Stock Option (Right to Buy) | +177,310 | 177,310 | ||
| 2020-04-22 | Bilbo Patrick Chief Operating Officer | Grant or award | +34,035 | 155,835 | ||
| 2020-04-22 | Bilbo Patrick Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +224,185 | 224,185 | ||
| 2020-04-22 | Grow Brian Chief Commercial Officer | Grant or award | +32,488 | 35,767 | ||
| 2020-04-22 | Grow Brian Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | +213,995 | 213,995 | ||
| 2020-04-22 | Cunningham Timothy M. Chief Financial Officer | Grant or award | +27,847 | 27,847 | ||
| 2020-04-22 | Cunningham Timothy M. Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +183,424 | 183,424 | ||
| 2020-04-22 | Gillheeney Gary S. President and CEO | Grant or award | +88,181 | 486,081 | ||
| 2020-04-22 | Gillheeney Gary S. President and CEO | Grant or award · Stock Option (Right to Buy) | +580,842 | 580,842 | ||
| 2020-04-22 | Montecalvo Antonio S. VP Health Policy & Contracting | Grant or award | +24,134 | 63,066 | ||
| 2020-04-22 | Montecalvo Antonio S. VP Health Policy & Contracting | Grant or award · Stock Option (Right to Buy) | +158,967 | 158,967 | ||
| 2020-04-14 | Grow Brian Chief Commercial Officer | Exercise or conversion | +1,150 | $1.70 | $2K | 3,279 |
| 2020-04-14 | Grow Brian Chief Commercial Officer | Exercise or conversion · Stock Option (Right to Buy) | −1,150 | 1 | ||
| 2020-03-16 | Avista Capital Managing Member IV, LLC Director | Purchase | +75,000 | $3.98 | $298K | 25,517,514 |
| 2020-03-13 | Avista Capital Managing Member IV, LLC Director | Purchase | +135,000 | $4.31 | $581K | 25,442,514 |
| 2020-03-12 | Avista Capital Managing Member IV, LLC Director | Purchase | +190,887 | $3.62 | $691K | 25,166,052 |
Page 26 of 32 · 627 trades